Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy

dc.contributor.author	Barros Tizón, Juan Carlos
dc.contributor.author	Torres Durán, María Luisa
dc.date.accessioned	2017-06-07T07:29:59Z
dc.date.available	2017-06-07T07:29:59Z
dc.date.issued	2012
dc.identifier.issn	1753-4658
dc.identifier.uri	http://hdl.handle.net/20.500.11940/7238
dc.language.iso	eng
dc.title	Reduction of severe exacerbations and hospitalization-derived costs in alpha-1-antitrypsin-deficient patients treated with alpha-1-antitrypsin augmentation therapy
dc.type	Artigo	es
dc.authorsophos	Barros-Tizon, J. C.
dc.authorsophos	Torres, M. L.
dc.authorsophos	Blanco, I.
dc.authorsophos	Martinez, M. T.
dc.identifier.doi	10.1177/1753465812438387
dc.identifier.pmid	22354900
dc.identifier.sophos	7189
dc.issue.number	2
dc.journal.title	Therapeutic advances in respiratory disease
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Vigo - Complexo Hospitalario Universitario de Vigo::Neumoloxía
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	6

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.